MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
63 hedge funds and large institutions have $33.6M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Holders
63
Holding in Top 10
–
Calls
$195K
Puts
$233K
Top Buyers
| 1 | +$1.39M | |
| 2 | +$560K | |
| 3 | +$417K | |
| 4 |
Two Sigma Investments
New York
|
+$302K |
| 5 |
JPMorgan Chase & Co
New York
|
+$293K |
Top Sellers
| 1 | -$539K | |
| 2 | -$338K | |
| 3 | -$307K | |
| 4 |
Morgan Stanley
New York
|
-$266K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$252K |